Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 81

1.

DAB2IP Downregulation Enhances the Proliferation and Metastasis of Human Gastric Cancer Cells by Derepressing the ERK1/2 Pathway.

Sun L, Yao Y, Lu T, Shang Z, Zhan S, Shi W, Pan G, Zhu X, He S.

Gastroenterol Res Pract. 2018 Mar 21;2018:2968252. doi: 10.1155/2018/2968252. eCollection 2018.

2.

Endothelial AIP1 Regulates Vascular Remodeling by Suppressing NADPH Oxidase-2.

Zhang J, Chen C, Li L, Zhou HJ, Li F, Zhang H, Yu L, Chen Y, Min W.

Front Physiol. 2018 Apr 20;9:396. doi: 10.3389/fphys.2018.00396. eCollection 2018.

3.

Low expression of DAB2IP predicts an unfavorable prognosis in human bladder carcinoma.

Zheng L, Chen K, Zhu L, Su D, Cheng G.

Onco Targets Ther. 2017 Nov 29;10:5719-5726. doi: 10.2147/OTT.S146952. eCollection 2017.

4.

Mapping the chromatin landscape and Blimp1 transcriptional targets that regulate trophoblast differentiation.

Nelson AC, Mould AW, Bikoff EK, Robertson EJ.

Sci Rep. 2017 Jul 28;7(1):6793. doi: 10.1038/s41598-017-06859-9.

5.

Cytolethal Distending Toxin Enhances Radiosensitivity in Prostate Cancer Cells by Regulating Autophagy.

Lin HJ, Liu HH, Lin CD, Kao MC, Chen YA, Chiang-Ni C, Jiang ZP, Huang MZ, Lin CJ, Lo UG, Lin LC, Lai CK, Lin H, Hsieh JT, Chiu CH, Lai CH.

Front Cell Infect Microbiol. 2017 Jun 8;7:223. doi: 10.3389/fcimb.2017.00223. eCollection 2017.

6.

Current Insights into Long Non-Coding RNAs (LncRNAs) in Prostate Cancer.

Smolle MA, Bauernhofer T, Pummer K, Calin GA, Pichler M.

Int J Mol Sci. 2017 Feb 22;18(2). pii: E473. doi: 10.3390/ijms18020473. Review.

7.

RASAL2, a RAS GTPase-activating protein, inhibits stemness and epithelial-mesenchymal transition via MAPK/SOX2 pathway in bladder cancer.

Hui K, Gao Y, Huang J, Xu S, Wang B, Zeng J, Fan J, Wang X, Yue Y, Wu S, Hsieh JT, He D, Wu K.

Cell Death Dis. 2017 Feb 9;8(2):e2600. doi: 10.1038/cddis.2017.9.

8.

HINT2 downregulation promotes colorectal carcinoma migration and metastasis.

Li W, Cai S, Wang L, Yang C, Zhou B, Wang H.

Oncotarget. 2017 Feb 21;8(8):13521-13531. doi: 10.18632/oncotarget.14587.

9.

Sensitization of Radioresistant Prostate Cancer Cells by Resveratrol Isolated from Arachis hypogaea Stems.

Chen YA, Lien HM, Kao MC, Lo UG, Lin LC, Lin CJ, Chang SJ, Chen CC, Hsieh JT, Lin H, Tang CH, Lai CH.

PLoS One. 2017 Jan 12;12(1):e0169204. doi: 10.1371/journal.pone.0169204. eCollection 2017.

10.

Block one, unleash a hundred. Mechanisms of DAB2IP inactivation in cancer.

Bellazzo A, Di Minin G, Collavin L.

Cell Death Differ. 2017 Jan;24(1):15-25. doi: 10.1038/cdd.2016.134. Epub 2016 Nov 18. Review.

11.

The degradation of EZH2 mediated by lncRNA ANCR attenuated the invasion and metastasis of breast cancer.

Li Z, Hou P, Fan D, Dong M, Ma M, Li H, Yao R, Li Y, Wang G, Geng P, Mihretab A, Liu D, Zhang Y, Huang B, Lu J.

Cell Death Differ. 2017 Jan;24(1):59-71. doi: 10.1038/cdd.2016.95. Epub 2016 Oct 7.

12.

Prognostic and clinicopathological value of Gli-1 expression in gastric cancer: A meta-analysis.

Lu L, Wu M, Zhao F, Fu W, Li W, Li X, Liu T.

Oncotarget. 2016 Oct 18;7(42):69087-69096. doi: 10.18632/oncotarget.12011. Review.

13.

Tumor suppressor protein DAB2IP participates in chromosomal stability maintenance through activating spindle assembly checkpoint and stabilizing kinetochore-microtubule attachments.

Yu L, Shang ZF, Abdisalaam S, Lee KJ, Gupta A, Hsieh JT, Asaithamby A, Chen BP, Saha D.

Nucleic Acids Res. 2016 Oct 14;44(18):8842-8854. Epub 2016 Aug 27.

14.

Validation of DAB2IP methylation and its relative significance in predicting outcome in renal cell carcinoma.

Wang ZR, Wei JH, Zhou JC, Haddad A, Zhao LY, Kapur P, Wu KJ, Wang B, Yu YH, Liao B, He DL, Chen W, Margulis V, Hsieh JT, Luo JH.

Oncotarget. 2016 May 24;7(21):31508-19. doi: 10.18632/oncotarget.8971.

15.

Smurf1 regulation of DAB2IP controls cell proliferation and migration.

Li X, Dai X, Wan L, Inuzuka H, Sun L, North BJ.

Oncotarget. 2016 May 3;7(18):26057-69. doi: 10.18632/oncotarget.8424.

16.

DAB2IP in cancer.

Liu L, Xu C, Hsieh JT, Gong J, Xie D.

Oncotarget. 2016 Jan 26;7(4):3766-76. doi: 10.18632/oncotarget.6501. Review.

17.

microRNA-32 induces radioresistance by targeting DAB2IP and regulating autophagy in prostate cancer cells.

Liao H, Xiao Y, Hu Y, Xiao Y, Yin Z, Liu L.

Oncol Lett. 2015 Oct;10(4):2055-2062. Epub 2015 Jul 30.

18.

Detection and Characterization of Metastatic Cancer Cells in the Mesogastrium of Gastric Cancer Patients.

Xie D, Liu L, Osaiweran H, Yu C, Sheng F, Gao C, Hu J, Gong J.

PLoS One. 2015 Nov 13;10(11):e0142970. doi: 10.1371/journal.pone.0142970. eCollection 2015. Erratum in: PLoS One. 2016;11(1):e0148681.

19.

Absence of DAB2IP promotes cancer stem cell like signatures and indicates poor survival outcome in colorectal cancer.

Min J, Liu L, Li X, Jiang J, Wang J, Zhang B, Cao D, Yu D, Tao D, Hu J, Gong J, Xie D.

Sci Rep. 2015 Nov 13;5:16578. doi: 10.1038/srep16578.

20.

LncRNA MALAT1 enhances oncogenic activities of EZH2 in castration-resistant prostate cancer.

Wang D, Ding L, Wang L, Zhao Y, Sun Z, Karnes RJ, Zhang J, Huang H.

Oncotarget. 2015 Dec 1;6(38):41045-55. doi: 10.18632/oncotarget.5728.

Supplemental Content

Support Center